Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-01-18 @ 5:51 PM
Study NCT ID:
NCT03085758
Status:
COMPLETED
Last Update Posted:
2024-02-21
First Post:
2017-02-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Treatment of Patients With Early Septic Shock and Bio-Adrenomedullin(ADM) Concentration > 70 pg/ml With ADRECIZUMAB
Sponsor:
Adrenomed AG
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-12
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-20
Completion Date Type:
ACTUAL
First Submit Date:
2017-02-22
First Submit QC Date:
None
Study First Post Date:
2017-03-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-12-17
Results First Submit QC Date:
None
Results First Post Date:
2021-03-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-31
Last Update Post Date:
2024-02-21
Last Update Post Date Type:
ACTUAL